Skip to main content

. 1980 Jan;17(1):92–95. doi: 10.1128/aac.17.1.92

In vitro studies of 1-oxacephalosporin (LY 127935), a new beta-lactam antibiotic.

S S Weaver, B M LeBlanc, G P Bodey

PMCID: PMC283733 PMID: 7352754

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

Neu H. C., Aswapokee N., Aswapokee P., Fu K. P. HR 756, a new cephalosporin active against gram-positive and gram-negative aerobic and anaerobic bacteria. Antimicrob Agents Chemother. 1979 Feb;15(2):273–281. doi: 10.1128/aac.15.2.273. [DOI] [PMC free article] [PubMed] [Google Scholar]
Neu H. C., Aswapokee N., Fu K. P., Aswapokee P. Antibacterial activity of a new 1-oxa cephalosporin compared with that of other beta-lactam compounds. Antimicrob Agents Chemother. 1979 Aug;16(2):141–149. doi: 10.1128/aac.16.2.141. [DOI] [PMC free article] [PubMed] [Google Scholar]
Snelling C. F., Ronald A. R., Cates C. Y., Forsythe W. C. Resistance of gram-negative bacilli to gentamicin. J Infect Dis. 1971 Dec;124 (Suppl):S264–S270. doi: 10.1093/infdis/124.supplement_1.s264. [DOI] [PubMed] [Google Scholar]
Valdivieso M., Bodey G. P. Amikacin therapy of severe infections produced by gram-negative bacilli resistant to gentamicin. Am J Med Sci. 1977 Mar-Apr;273(2):177–184. doi: 10.1097/00000441-197703000-00007. [DOI] [PubMed] [Google Scholar]
Weaver S. S., LeBlanc B. M., Bodey G. P. BL-S786 (ceforanide), a new parenteral cephalosporin: in vitro studies. Antimicrob Agents Chemother. 1979 Feb;15(2):318–322. doi: 10.1128/aac.15.2.318. [DOI] [PMC free article] [PubMed] [Google Scholar]

ACTIONS

RESOURCES